Clinical Trial Update: A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS) [NA]

View source ↗

Summary

This clinical trial profile from The Netherlands Cancer Institute describes a platform using patient-derived xenografts and 2D/3D cell cultures to model soft ti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Soft Tissue Sarcoma, Xenograft Model | NA | Status: RECRUITING